Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy

George D. Demetri, Jean‐Yves Blay, Daniel A. Rushing et al.|Journal of Clinical Oncology|2013

Cited by 243